The effects of combined treatment of losartan and ramipril on hypertension and related complications

被引:0
作者
Hyun-Soo Park
Do-Hyung Lee
Joo-Hui Han
Sang-Hyuk Jung
Miji Lee
Keun-Woo Jang
Chang-Seon Myung
机构
[1] Chungnam National University College of Pharmacy,Department of Pharmacology
来源
Journal of Pharmaceutical Investigation | 2020年 / 50卷
关键词
Losartan; Ramipril; Combination therapy; Hypertension; Vascular remodeling;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:573 / 581
页数:8
相关论文
共 181 条
[1]  
Alexander RW(1995)Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective Hypertension 25 155-161
[2]  
Arauz-Pacheco C(2003)Treatment of hypertension in adults with diabetes Diabetes Care 26 S80-82
[3]  
Parrott MA(2018)Combination therapy is a new standard for treatment of pulmonary arterial hypertension Ter Arkh 90 72-80
[4]  
Raskin P(2019)Global impact of the new European and American hypertension guidelines: a perspective from Lebanon J Clin Hypertens (Greenwich) 21 684-686
[5]  
American Diabetes A(2018)Blood pressure in acute stroke: to treat or not to treat: that is still the question Stroke 49 1784-1790
[6]  
Avdeev SN(1987)Ramipril: review of pharmacology Am J Cardiol 59 3D-11D
[7]  
TsarEva NA(2015)Cell proliferation method: click chemistry based on BrdU coupling for multiplex antibody staining Curr Protoc Cytom 72 1-17
[8]  
Gaisin IR(2009)Dual renin-angiotensin system blockade in the ONTARGET study: clinically relevant risk for the kidney? Curr Hypertens Rep 11 375-381
[9]  
Azar RR(2018)First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension Cochrane Database Syst Rev 11 CD008170-481
[10]  
Sarkis A(2015)Inhibition of the nitric oxide/cyclic guanosine monophosphate pathway limited the cardioprotective effect of post-conditioning in hearts with apical myocardial infarction Eur J Pharmacol 765 472-697